FKTN and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Although FKTN is associated with dystroglycanopathy usually in the context of homozygous or compound heterozygous variants32–34, the enrichment of heterozygous regulatory variants in our cohort may suggest a contributory role for this gene in CMP.